University of Patras
Μελέτη του ρόλου της ενδοθηλίνης και των υποδοχέων της στην επιθηλιομεσεγχυματική μετατροπή στο αδενοκαρκίνωμα του προστάτη
Abstract
dc:descriptionEpithelial to Mesenchymal Transition (EMT) is part of a mechanism that is physiologically activated during embryogenesis and wound healing. EMT is a molecular mechanism that, as indicated by its name, confers mesenchymal properties on epithelial cells, such as increased invasiveness and migration, making it a process closely associated with acquisition of aggressive traits by carcinoma cells.The endothelin axis plays a central role in neoplasia, with endothelin 1 (ET-1) mediating a mitogenic effect on epithelial or other carcinomas through its receptors A(ET-A) and B (ET-B). Activation of the endothelin axis induces proliferation,apoptosis resistance and new vessel formation and also modulates immune responses and drug resistance.In the present study the expression of molecular markers modulated during EMT and their possible relationship with the endothelin axis was investigated by immunohistochemistry in prostate cancer. Antibodies for the adherence molecules, E and N-cadherins, transcription factor SNAIL as well as for the endothelin ET-1 and its receptors ET-A and ET-B were used. The tissue samples were obtained from 87 patients with prostate cancer, between the ages of 51 and 75. The expression of the investigated molecules was estimated in neoplasm tissue (cancer cells) and in the adjacent “non-neoplastic” tissue, whereas the cellular localization (membrane,cytoplasm, nucleus) was determined. The patient’s samples were categorized according to: age, Gleason score (Grade I, Gleason score 2-6, Grade II, Gleason scοre 7 (3+4 ή 4+3), Grade III, Gleason scοre 8-10), stage Τ and Ν (presence or not of positive lymph nodes).In the adjacent “normal” non neoplastic epithelium the expression of E cadherin and b-catenin was strong at the membrane, with N-cadherin being expressed in medium levels at the membrane as well as the cytoplasm and SNAIL showing low nuclear levels. In accordance, vimentin was negative in all samples, while ET-1 andET-A were present in the cytoplasm at low levels.In contrast, in prostate carcinoma E- and N-cadherin were low at the membrane and medium to high at the cytoplasm, together with b-catenin that was also reduced at the membrane, but was increased in the cytoplasm and the nucleus.Vimentin was positive in the cancer cells and SNAIL was present at medium to high levels in the nucleus of the cancer cells. ET-1 and ET-A were located with increased levels in the cytoplasm of the cancer cells, whereas ET-B was negative for all samples.The statistical analysis indicated significant associations between the markers of EMT and the endothelin axis with the clinocopathological characteristics (lymph node,T stage and Gleason Score). The increased nuclear levels of Snail and the cytoplasmic levels of ET-1 and ET-A were associated with all the investigated clinicalparameters. The expression of N-cadherin at the cytoplasm and the membrane significantly correlated with the presence of lymph nodes and T stage of the tumor,whereas cytoplasmic b-catenin correlated with the lymph node status and cytoplasmic E-cadherin with the Gleason score.Furthermore, nuclear E-cadherin positively correlated with the expression of E-cadherin in both the cytoplasm and the membrane, with E-cadherin levels at thecytoplasm being positively correlated with the expression of ET-1 and ET-A. In this respect, ET-1 positively correlated with cytoplasmic b-catenin and negatively correlated with her expression at the membrane, while SNAIL showed a positive correlation with the expression of ET-1 and ET-A. In conclusion, in the present study the existence of EMT and its association with the ET-1/ET-A axis was verified in prostate cancer. The transcription factor SNAIL seems to play a pivotal role in the crosstalking of these two pathways. The increased expression of the EMT markers as well as those of SNAIL, ET-1/ET-A correlated with lymph node, stage T and Gleason score. These findings make the prospect of molecular cancer staging attractive and emphasize the rationale of the development of new therapeutic approaches with specific EMT /endothelin axis inhibitors in the treatment of prostate cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papanikolaou, Sofia
- Παπανικολάου, Σοφία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35853